Potentiation of Therapeutic Effects of Nicotinic Acid by Pyridoxine in Chronic Schizophrenics *

Awapara J. , Landua A. J. Feurst R. and Seale B. J. : Free gamma amino butyric acid in brain. J. Biol. Chem. 187: 35-39, 1950.

Ban T. A. : Niacin in the treatment of schizophrenias. Psychopharmacol. Bull. 5(3): 5–20, 1969.

Ban T. A. and Lehmann H. E. : Nicotinic acid in the treatment of schizophrenias. Canadian Mental Health Association Collaborative Study. Progress Report I. Canadian Mental Health Association, 1970.

Barbeau A. and Sourkes T. L. : “Some biochemical aspects of extrapyramidal diseases.” In: Extrapyramidal System and Neuroleptics, Bordeleau J. M. (Ed.). Montreal, L'Edition Psychiatrie p. 101–107, 1961.

Baron D. N. , Dent C. E. , Harris H. , Hart E. W. and Jepson J. B. : Hereditary pellagra-like skin rash with temporary cerebellar ataxia. Constant renal aminaciduria and other bizarre biochemical features. Lancet 2: 421-428, 1956.

Baumblatt M. J. and Winston F. : Pyridoxine and the pill. Lancet (Lett) 1: 832-833, 1970.

Bicknell F. and Prescott F. : The Vitamins in Medicine (3rd edition). Heinmann W. (ed.). London, New York, Grune and Stratton, p. 352, 1953.

Brune G. G. and Himwich H. E. : “Biogenic amines and behavior in schizophrenic patients.” In: Recent Advances in Biological Psychiatry, Wortis J. , (ed.). New York, Plenum Press, p. 144–166, 1963.

Cleckley H. M. , Sydenstricker L. E. and Geaslin L. E. : Nicotinic acid in treatment of atypical psychotic states associated with malnutrition. J.A.M.A. 112: 2107-2110, 1939.

DiLorenzo P. A. : Pellagra-like syndromes associated with isoniazid therapy. Acta Dermato Vener. 47: 318-322, 1967.

Frimptor G. E. , Andelman R. J. and George W. E. : Vitamin B6-dependency syndromes: new horizons in nutrition. Am. J. Clin. Nutr. 22: 794-805, 1969.

Hersov L. A. : A case of childhood pellagra with psychosis. J. Ment. Sci. 101: 878-883, 1955.

Hoffer A. and Osmond H. : Some schizophrenic recoveries. Dis. Nerv. Syst. 23: 204-210, 1962.

Hoffer A. and Osmond H. : Treatment of schizophrenia with a nicotinic acid (a ten-year follow-up). Acta Psychiat. Scand. 40: 171-189, 1964.

Hôningfeld G. and Klett C. J. : The nurses observation scale for inpatient evaluation: a new scale for measuring improvement in chronic schizophrenia. Clin. Psychol. 21: 65-71, 1965.

Hunt A. D. Jr. , Stokes J. Jr. , McCrory W. W. and Stroud H. H. : Pyridoxine dependency: report of a case of intractable convulsions in an infant controlled by pyridoxine. Paediatrics 13: 140-145, 1954.

Janssen P. A. J. : The pharmacological and clinical mode of action of neuroleptic drugs. J. Clin. Trials 2: 370-379, 1966.

Matsuo Y. and Greenberg D. M. : Acry-stalline enzyme that cleaves homoserine and crystathionine. Isolation procedure and some physiochemical properties. J. Biol. Chem. 230: 545-560, 1958.

Meisler A. : Biochemistry of the Amino Acids. (2nd edition). New York, New York Academy Press, 1965.

Mosher L. R. : Nicotinic acid side effects and toxicity: a review. Am. J. Psychiatry 126: 1240-1296, 1970.

Osmond H. and Hoffer A. : Massive niacin treatment in schizophrenia: review of a nine year study. Lancet I: 316–319 1962.

Overall J. E. and Gorham D. R. : The Brief Psychiatric Rating Scale (BPRS). Psychol. Rep. 10: 799-812, 1962.

Pauling L. : Orthomolecular psychiatry. Science 160: 265-271, 1968.

Perry T. L. : Unsolved problems in homocystinuria. In: Amino Acid Metabolism and Genetic Variation. Ed. Nyhan W. L. New York, McGraw-Hill. 1957.

Price J. M. , Brown R. R. and Peters H. A. : Tryptophan metabolism in porphyria, schizophrenia and a variety of neurologic and psychiatric diseases. Neurology 9: 456-468, 1959.

Roberts E. , Harman P. J. and Frankel S. : Gamma amino butyric acid content and glutamic decarboxylase activity in the developing mouse brain. Proc. Soc. Exp. Biol. Med. 78: 799-803, 1951.

Scriver C. R. : Vitamin B6 dependency and infantile convulsions. Paediatrics 26: 62-74, 1960.

Sourkes T. L. : Biochemistry of Mental Disease. New York, Harper and Row, Hoeber Medical Division. 1962.

Stucki A. : Uber psychologische Reaktionen bei tuberculostatischer Behandlung (cycloserine and INH). Praxis 50: 592-595, 1961.

Tower D. B. : Neurochemical aspects of pyridoxine metabolism and function. Am. J. Clin. Nutr. 4: 329-345, 1956.

Tower D. B. : Nutritional reviews. 16: 161-164, 1958.

Udenfriend S. , Weissbach H. and Bogdanski D. F. : Biochemical findings relating to the action of serotonin. Ann. New York Acad. Sci. 66(3): 602-608, 1957.